Clinical Trials Logo
  1. Home
  2. Cystitis, Interstitial
  3. NCT05752344

Interstitial Cystitis: Monitoring of the Psychic State and Counseling Intervention in the COVID-19 Era

Cystitis, Interstitial Clinical Trial

Official title:
Interstitial Cystitis: Monitoring of the Psychic State and Counseling Intervention in the COVID-19 Era

Clinical Trial Summary

The target population of this observational study is made up of all patients belonging to the Interstitial Cystitis pathway of the Gemelli University Hospital Foundation - IRCCS, who have accepted to be subjected to remote monitoring and diagnostic investigation. The aim of the study is the evaluation of some outcome parameters at the time of enrollment (T0), and at the end (T1) of subjects affected by Intersitial Cystitis who have carried out a monitoring of the dimensions of the psychic sphere concerning: depression, trait anxiety, state anxiety , well-being, self-efficacy, resilience.The objective is also to evaluate the presence of evolutionary and maturational trends in the mental set-up of the people who participated in the individual counseling intervention.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05752344
Study type Observational
Source Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Contact
Status Completed
Phase
Start date November 1, 2020
Completion date November 1, 2022
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT02868775 - A Study to Determine the Role of Toll-like Receptor-4 Expression in Patients With Interstitial Cystitis/Bladder Pain Syndrome N/A
Completed NCT00672087 - Diagnostic Challenges in IC (and Male CPPS)
Completed NCT01482676 - The Role of microRNAs in Organ Remodeling in Lower Urinary Tract Dysfunction N/A
Completed NCT00775281 - Changes in Inflammatory and Contractile Protein Expression in Patients With Painful Bladder Syndrome/IC. N/A
Terminated NCT00380783 - Safety and Efficacy of AGN 203818 for Pain Associated With Painful Bladder Syndrome/Interstitial Cystitis Phase 2
Completed NCT05260112 - Smartphone-based Self-care Education Program for Women With Interstitial Cystitis: Educational Remote IC Aide N/A
Completed NCT01613586 - A Randomized Study Comparing Placebo and ASP3652 in the Treatment of Women With Bladder Pain Syndrome / Interstitial Cystitis (BPS/IC) Phase 2
Completed NCT02411110 - A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis/Bladder Pain Syndrome Phase 2
Recruiting NCT06299683 - Pain Type and Interstitial Cystitis/Bladder Pain Syndrome Treatment N/A
Completed NCT00248664 - Events Preceding Interstitial Cystitis (EPIC) N/A
Completed NCT00601484 - An Effectiveness and Safety Study of PF-04383119 for the Treatment of Pain in Interstitial Cystitis Phase 2
Completed NCT02214550 - Chronic Pain Risk Associated With Menstrual Period Pain Phase 4
Completed NCT04275297 - Optimizing Psychosocial Treatment of Interstitial Cystitis/Bladder Pain Syndrome N/A
Terminated NCT00999518 - A Study To Investigate Tanezumab In Patients With Interstitial Cystitis/ Painful Bladder Syndrome Phase 2
Completed NCT00675298 - Linkage Analysis in Interstitial Cystitis N/A
Terminated NCT02781103 - Guided Imagery and Transcranial Direct Current Stimulation (tDCS) in Women With Chronic Pelvic Pain N/A
Recruiting NCT01074567 - DMSO Efficacy in IC/PBS Patients During and After Treatment N/A
Completed NCT02497976 - Pilot Study Evaluating the Efficacy of Certolizumab Pegol for Interstitial Cystitis Phase 3
Terminated NCT02787083 - A Pilot Study of the Effects of Mirabegron on Symptoms in Patients With Interstitial Cystitis Phase 3
Withdrawn NCT00275379 - Study Evaluating Orally Administered ERB-041 in Subjects With Active Interstitial Cystitis N/A